Feature Channels: Immunology

Filters close
Released: 5-May-2023 5:15 PM EDT
Study reveals insights into post-vaccine heart inflammation cases
Yale University

When new COVID-19 vaccines were first administered two years ago, public health officials found an increase in cases of myocarditis, an inflammation of the heart muscle, particularly among young males who had been vaccinated with mRNA vaccines. It was unclear, however, what exactly was causing this reaction.

Newswise:Video Embedded live-event-for-may-3-study-of-rebyota-fecal-microbiota-on-patients-with-c-diff-infection
VIDEO
Released: 5-May-2023 10:25 AM EDT
Video and transcript: Study of fecal microbiota on patients with C. diff infection
Newswise

The researcher discusses the findings in a new study on the efficacy and safety of fecal microbiota (REBYOTA™), the first microbiota-based live biotherapeutic approved by the US FDA used to prevent recurrent Clostridioides difficile infection in adults.

3-May-2023 4:25 PM EDT
Study Identifies Messages about Vaccinating Children Against COVID-19 That Resonate Best with Vaccine-Hesitant Parents
Ann and Robert H. Lurie Children's Hospital of Chicago

A study from Ann & Robert H. Lurie Children’s Hospital of Chicago found that parents with children who were not yet vaccinated against COVID-19 were most likely to vaccinate their child after reading the following hypothetical scenario.

Newswise: Gamma delta T cells can fight aggressive breast cancer
Released: 4-May-2023 7:20 PM EDT
Gamma delta T cells can fight aggressive breast cancer
University of Freiburg

Researchers from the University of Frieburg discovered that coordinated differentiation and changes in the metabolism of breast cancer stem cells make them invisible for the immune system.

Newswise: The Medical Minute: Crohn’s disease has no cure, but new treatments bring hope
Released: 4-May-2023 7:05 AM EDT
The Medical Minute: Crohn’s disease has no cure, but new treatments bring hope
Penn State Health

Anyone newly diagnosed with Crohn’s disease probably has some anxiety about having a chronic ailment for which there’s no cure. A Penn State Health doctor talks about how treatments and medication offer reason for hope.

Newswise: Reviving exhausted T cells to tackle immunotherapy-resistant cancers
Released: 3-May-2023 5:55 PM EDT
Reviving exhausted T cells to tackle immunotherapy-resistant cancers
Sanford Burnham Prebys

One of the biggest goals of immunotherapy is to reverse T cell exhaustion to boost the immune system’s ability to destroy cancerous cells. Researchers at Sanford Burnham Prebys studying melanoma have found a new way to make this happen.

Newswise: Stephen J. Galli, MD, to Receive 2024 American Society for Investigative Pathology Gold-Headed Cane Award
Released: 3-May-2023 5:00 PM EDT
Stephen J. Galli, MD, to Receive 2024 American Society for Investigative Pathology Gold-Headed Cane Award
Federation of American Societies for Experimental Biology (FASEB)

The American Society for Investigative Pathology awards Stephen J. Galli, MD, the 2024 ASIP Gold-Headed Cane Award.

Newswise: Digestive Disease Week 2023: Cedars-Sinai Experts Share Latest Research, Care Innovations
Released: 3-May-2023 4:40 PM EDT
Digestive Disease Week 2023: Cedars-Sinai Experts Share Latest Research, Care Innovations
Cedars-Sinai

Digestive Disease Week (DDW) is the largest international gathering of physicians, researchers, and academics in the fields of gastroenterology, hepatology, endoscopy, and gastrointestinal surgery. DDW2023 will take place May 6-9 in Chicago and showcase 3,100 abstracts and hundreds of lectures on the latest advances in GI research, clinical practice and technology.

Released: 3-May-2023 3:15 PM EDT
Moffitt Researchers Develop CAR T Cells that Fight Prostate Cancer in Bone
Moffitt Cancer Center

Prostate cancer frequently metastasizes to the bone and is incurable. Moffitt Cancer Center researchers are working to identify new treatment options for this subset of patients. In a new article published today in Science Advances, a team of Moffitt scientists demonstrates that chimeric antigen receptor T-cell (CAR T) therapy is an effective antitumor approach in mouse models of bone metastatic prostate cancer.



close
2.22122